Zymeworks (ZYME) Net Cash Flow (2021 - 2026)

Zymeworks has reported Net Cash Flow for 6 years, with the latest figure at $203.0 million in Q1 2026.

• Quarterly Net Cash Flow rose 1911.96% year-over-year to $203.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $168.0 million (up 533.23% YoY) and the FY2025 annual result came in at -$24.9 million, up 72.86% from the prior year.
• Net Cash Flow grew to $203.0 million in Q1 2026 per ZYME's latest filing, from -$23.6 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $304.9 million in Q4 2022 and troughed at -$219.7 million in Q1 2023.
• A 5-year average of $2.4 million and a median of -$33.5 million in 2025 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2026: Net Cash Flow tumbled 397.78% in 2023, then soared 1911.96% in 2026.
• Over 5 years, Net Cash Flow stood at $304.9 million in 2022, then tumbled by 79.26% to $63.2 million in 2023, then plunged by 189.15% to -$56.4 million in 2024, then jumped by 58.07% to -$23.6 million in 2025, then soared by 959.08% to $203.0 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $203.0 million, -$23.6 million, and -$33.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.